Valuation : Formosa Laboratories, Inc.

Market Cap 558.59Cr 18Cr 15Cr 14Cr 13Cr 24Cr 1.69TCr 25Cr 170.52Cr 66Cr 855.67Cr 66Cr 65Cr 2.72TCr P/E 2024
52.9x
P/E 2025 16.3x
Enterprise Value 670.13Cr 21Cr 18Cr 17Cr 16Cr 29Cr 2.02TCr 30Cr 204.57Cr 79Cr 1.03TCr 79Cr 78Cr 3.26TCr EV / Sales 2024
2x
EV / Sales 2025 1.7x
Free-Float
78.86%
Yield 2024
4.36%
Yield 2025 5.06%
1 day+1.42%
1 week+0.98%
Current month-4.72%
1 month-14.61%
3 months-10.33%
6 months-10.15%
Current year-21.67%
1 week 45.15
Extreme 45.15
46.7
1 month 45
Extreme 45
55.5
Current year 45
Extreme 45
62.5
1 year 45
Extreme 45
68.7
3 years 45
Extreme 45
121
5 years 44.2
Extreme 44.2
121
10 years 29.75
Extreme 29.75
121
Manager TitleAgeSince
Chief Executive Officer - 01/01/1996
Director of Finance/CFO - 14/04/2003
Investor Relations Contact - -
Director TitleAgeSince
Chairman - 01/01/1996
Director/Board Member - 18/06/2012
Director/Board Member - 28/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%+0.98%-30.98%-48.39% 17Cr
-0.11%-3.16%+48.82%+91.49% 1,00200Cr
-0.27%-4.34%+51.52%+65.89% 64TCr
+1.63%-2.00%+20.49%+71.12% 44TCr
-0.63%-3.09%+29.84%+34.59% 34TCr
+0.43%-14.61%+11.32%+27.26% 26TCr
+0.93%-3.19%-1.31%+8.41% 24TCr
-2.25%-13.88%+37.33%+47.43% 21TCr
-0.90%-5.06%-18.47%-57.75% 20TCr
-0.58%-4.24%+25.65%+90.54% 18TCr
Average +0.04%-4.42%+17.42%+33.06% 35.3TCr
Weighted average by Cap. +0.07%-4.39%+31.98%+57.11%

Financials

2024 2025
Net sales 473.1Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 144.42Cr 56Cr 724.73Cr 56Cr 55Cr 2.3TCr 485.14Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.47TCr 21Cr 148.1Cr 57Cr 743.16Cr 58Cr 56Cr 2.36TCr
Net income 16Cr 49.68L 42.72L 40.31L 36.72L 68.65L 47Cr 69.27L 4.8Cr 1.85Cr 24Cr 1.87Cr 1.82Cr 77Cr 44Cr 1.39Cr 1.2Cr 1.13Cr 1.03Cr 1.93Cr 133.22Cr 1.94Cr 13Cr 5.18Cr 68Cr 5.23Cr 5.12Cr 214.62Cr
Net Debt 119.6Cr 3.78Cr 3.25Cr 3.07Cr 2.79Cr 5.22Cr 361.2Cr 5.27Cr 37Cr 14Cr 183.2Cr 14Cr 14Cr 581.91Cr 111.54Cr 3.52Cr 3.03Cr 2.86Cr 2.6Cr 4.87Cr 336.88Cr 4.91Cr 34Cr 13Cr 170.87Cr 13Cr 13Cr 542.73Cr
Logo Formosa Laboratories, Inc.
Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.
Employees
-
Date Price Change Volume
10/26/10 NT$46.45 +1.42% 5,24,866
09/26/09 NT$45.80 +0.55% 4,70,788
08/26/08 NT$45.55 -1.83% 8,23,677
07/26/07 NT$46.40 +2.32% 8,62,577
04/26/04 NT$45.35 -1.41% 8,56,389

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4746 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!